Generated by All in One SEO v4.9.5.1, this is an llms.txt file, used by LLMs to index the site. # Haemair ## Posts - [News](https://www.haemair.com/news/) - Stay up-to-date with the latest industry news here. - [Haemair publishes results of blood-treating device](https://www.haemair.com/2024/09/27/haemair-publishes-results-of-blood-treating-device/) - The work showed that potentially harmful components that accumulate during storage of transfusion blood (red cell concentrate, RCC) can be removed without damaging red blood cells. The prospect of further improving the quality of blood transfusion is particularly important for people needing repeated transfusions. - [Haemair pump in circuit that maintains kidney viability ex-vivo for 48 hours](https://www.haemair.com/2025/04/25/haemair-pump-in-circuit-that-maintains-kidney-viability-ex-vivo-for-48-hours/) - Extended ex-vivo perfusion tests of porcine kidneys have been conducted. Circuits driven by the Haemair pulsatile pump showed improved urine production and reduced resistance to blood flow through the kidneys compared to circuits driven by a widely-used centrifugal blood pump. In stand-alone tests, the Haemair pump also shows reduced haemolysis. - [Haemair granted US patent](https://www.haemair.com/2025/02/25/haemair-granted-us-patent/) - Haemair granted US patent for a cell washing apparatus (applicable to improved blood transfusion). ## Pages - [Welcome to Haemair](https://www.haemair.com/) - Developing Life-saving Technology Our mission – our skills Haemair has created a range of related technologies built on skills in the physical and chemical properties of blood. All have the objective of saving and improving lives in a cost-effective manner. Our focus is on developing and commercializing these technologies; we are seeking collaborators to work - [Blood Oxygenator](https://www.haemair.com/product-development/blood-oxygenator/) - A novel, compact oxygenator Virtually all current blood oxygenators employ hollow fibre membranes. In these devices, oxygen flows through the hollow fibres and blood flows around them. Different manufacturers organize the flow paths differently. For example, the hollow fibres may be straight with the blood flow at right angles to the fibres. Other devices have - [Contact](https://www.haemair.com/contact/) - To find out more information, please email us at: info@haemair.com - [Product Development](https://www.haemair.com/product-development/) - ECLS systems include a blood oxygenator, a pump and associated equipment to connect the system to the patient’s blood circulation. - [Acute Respiratory Distress Syndrome and Acute Kidney Injury](https://www.haemair.com/product-development/treatment-of-comorbidities-of-ards-and-aki/) - Treatment of comorbidities of ARDS and AKI A device for treating comorbidities associated with high mortality rates During the Covid-19 pandemic, Acute Respiratory Distress Syndrome (ARDS) came to prominence as a major cause of illness and death. However, even before the pandemic, the condition was a significant cause of mortality resulting in around 5 deaths - [Blood Pump](https://www.haemair.com/product-development/blood-pump/) - A novel pulsatile, low haemolysis blood pump All mammals have evolved with beating hearts. Every organ and tissue in the body has evolved to expect a pulsing blood flow. The size and shape of the pulses depends on the position in the body, but all expect a pulsing flow. A pulsing flow delivers more energy - [Blood Rheology](https://www.haemair.com/product-development/blood-rheology/) - Measuring the propensity of blood to clot Haemair set out to develop a complete portable extracorporeal life support system with pump, oxygenator, control system and instrumentation. One of the instruments that we set out to develop was a blood rheometer to measure the tendency of blood to clot. We considered that such an instrument would - [Autonomic Control](https://www.haemair.com/product-development/autonomic-control/) - Autonomic Control of ECLS A system to reduce risk and improve management of patients on ECLS systems In a healthy person, the natural built-in Autonomic Nervous System provides: Feedback control of ventilation rate and cardiac output from chemoreceptors that measure blood gas partial pressures Anticipatory control: adjusts ventilation rate and cardiac output in anticipation of - [Collaborations](https://www.haemair.com/collaborations/) - Haemair welcomes collaborations and partnerships with organizations working in complementary areas: Examples of collaborations include: Swansea University (supported by the Welsh Government). The collaboration is outlined in the following Youtube video: www.youtube.com/watch?v=4Y0vM0UQacc Welsh Blood Service: Results from some of our work are summarized in the joint poster presented at the 2024 meeting of the British - [Shareholders](https://www.haemair.com/shareholders/) - Haemair currently has over 70 shareholders who share our vision of improving peoples’ lives through advanced medical devices. We welcome new shareholders and partners. For enquiries, please contact: info@haemair.com Alternatively: Contact us at: Haemair Limited, Room 403 ILS2, Swansea University, Singleton Park, Swansea SA2 8PP - [Blood Transfusion](https://www.haemair.com/product-development/blood-transfusion/) - A device to reduce to reduce the risk to patients and extend the life of stored blood by reducing the concentrations of toxic species that accumulate in stored blood during storage. During storage, transfusion blood (packed cells) deteriorates and toxic species accumulate in the blood. Accumulation of these species limits the shelf-life of the blood. - [About Us](https://www.haemair.com/about-us/) - Haemair was founded in 2005 by engineers with close relatives who had suffered and died of lung disease. - [Privacy Policy](https://www.haemair.com/privacy-policy/) - This privacy policy governs the privacy of this website [haemai99.vm007.innermedia.co.uk/] and its users who choose to use it. - [Organ Perfusion System](https://www.haemair.com/product-development/organ-perfusion-system/) - A system to perfuse organs giving longer viable life ex-vivo using our own pump and oxygenator There is an increasing demand for ex-vivo perfusion of individual organs and tissues to maintain viability for extended periods. The system meets at least 3 needs, namely drug testing, transplant organ perfusion, and ex-vivo treatment of disease. Drug testing: - [Vacancies](https://www.haemair.com/about-us/vacancies/) - Haemair Ltd is currently recruiting for the following Positions. ## Case Studies - [Novel ECMO Device Development](https://www.haemair.com/our-clients/case-study-title/) - Established in 2005 and based in Swansea, Haemair is developing the next generation Extracorporeal Membrane Oxygenation (ECMO) device. The initial focus is on post-operative support following cardio pulmonary surgery where it can both improve recovery rates and reduce hospital stays. ## Categories - [Blog](https://www.haemair.com/category/blog/)